Chemical Composition of Traditional and Analog Ayahuasca
Helle Kaasik, Rita C. Z. Souza, Flávia Da Silva Zandonadi, Luís Fernando Tófoli, Alessandra Sussulini
Journal of Psychoactive Drugs September 8, 2020 DOI: 10.1080/02791072.2020.1815911 via OpenAlex
Summary
AI-generated from the abstractAyahuasca brews from different traditions vary widely in their psychoactive components. Analysis of 102 samples from indigenous, religious, and neoshamanic communities showed that neoshamanic brews contain higher and more variable concentrations of DMT, likely from using larger or more variable amounts of DMT-containing plants. European samples included two instances of analog ayahuasca containing moclobemide, psilocin, DMT, and yuremamine, with very low levels of Banisteriopsis caapi alkaloids, and some used Peganum harmala and Mimosa tenuiflora. No analogs appeared in Brazilian or Santo Daime samples. The findings highlight the need for awareness and ethical self-regulation among practitioners.
Study at a glance
| Characteristics | Cross-sectional analytical study Qualitative Peer reviewed |
|---|---|
| Sample size | 102 |
| Population | Ayahuasca brews from indigenous, religious, and neoshamanic communities in Brazil and Europe |
| Topics | Ayahuasca |
| Keywords | Peganum harmala Harmaline Harmine Amazon rainforest |
| Citations | 54 |
| Key finding | Neoshamanic ayahuasca samples had higher and more variable DMT concentrations than indigenous samples, and some European samples were analog brews lacking traditional B. caapi alkaloids. |
Abstract
Traditional ayahuasca can be defined as a brew made from Amazonian vine Banisteriopsis caapi and Amazonian admixture plants. Ayahuasca is used by indigenous groups in Amazonia, as a sacrament in syncretic Brazilian religions, and in healing and spiritual ceremonies internationally. The study aimed to determine concentrations of the main bio- and psychoactive components of ayahuasca used in different locations and traditions. We collected 102 samples of brews from ayahuasca-using communities. Concentrations of N,N-dimethyltryptamine (DMT), tetrahydroharmine, harmine, and harmaline were determined by ultra-high performance liquid chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS). Qualitative analyses for non-traditional additives (moclobemide, psilocin, yuremamine) were performed by high resolution mass spectrometry. Higher and more variable concentrations of DMT in neoshamanic ayahuasca samples compared to indigenous samples may indicate use of higher and more variable proportions of DMT-containing admixture plants. From European samples, we found two related samples of analog ayahuasca containing moclobemide, psilocin, DMT, yuremamine, and very low concentrations of B. caapi alkaloids. Some analogs of ayahuasca (Peganum harmala, Mimosa tenuiflora) were used in Europe. No analogs were found from Brazil or Santo Daime ceremonies in Europe. We recommend awareness about the constituents of the brew and ethical self-regulation among practitioners of ayahuasca ceremonies.